Cargando…
Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells
PURPOSE: The toxicity of antiglaucoma medications to ocular surface cells has been evaluated extensively; however, the toxicity to corneal endothelial cells (CECs) remains elusive. Our aim is to evaluate the toxicity of antiglaucoma medications to CECs using an in vitro toxicity assay. METHODS: Prim...
Autores principales: | Ayaki, Masahiko, Iwasawa, Atsuo, Inoue, Yoichi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964961/ https://www.ncbi.nlm.nih.gov/pubmed/21060675 http://dx.doi.org/10.2147/OPTH.S13708 |
Ejemplares similares
-
Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
por: Ayaki, Masahiko, et al.
Publicado: (2010) -
Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
por: Louati, Y, et al.
Publicado: (2012) -
Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines
por: Ayaki, Masahiko, et al.
Publicado: (2010) -
Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applications
por: Meloni, Marisa, et al.
Publicado: (2012) -
Corneal Alternations Induced by Topical Application of Benzalkonium Chloride in Rabbit
por: Chen, Wensheng, et al.
Publicado: (2011)